Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease

Exclusion Criteria

• •Complex and Unstable IBD:
• •Currently or within the past 9 months has had an abscess, fistula, stricturing CD, or ostomy
• •Severe disease activity as measured by a short Pediatric Crohn's Disease Activity Index (SPCDAI) score of \>45 or Pediatric Ulcerative Colitis Activity Index (PUCAI) score of \>60 assessed within three weeks of enrollment
• •Ever had history of full colectomy
• •Hospitalization or surgery planned within 3 months
• •Ongoing active gastrointestinal infection
• •Severe Malnutrition (BMI less than 5th percentile)
• •Recent medication changes including:
• •* Thiopurines, natalizumab, or methotrexate started within 8 weeks prior to enrollment
• •* Anti TNF (infliximab, adalimumab) started within 8 weeks prior to enrollment
• •* Vedolizumab started within 16 weeks prior to enrollment
• •* Increase in corticosteroids within 4 weeks of screening or have dose \>20 mg prednisone or equivalent
• •Evidence of Other Complicating Medical Issues:
• •Other serious medical conditions, such as neurological, liver, kidney, or systemic disease
• •Serious psychological or psychiatric conditions such as eating disorders or self-harm
• •Pregnancy
• •Tobacco, alcohol, or illicit drug abuse
• •Inability to Complete the Protocol
• •Non-English speaking participants
• •On SCD or modified SCD anytime within 8 weeks of enrollment
• •* If an otherwise eligible patient is on SCD or modified SCD within 8 weeks of enrollment but they are noncompliant per the determination of the patient's dietitian/primary gastroenterologist, then this patient is eligible to participant in the study.
• •Participants on a vegan diet
• •Lack of smart phone and data plan for participating caregiver
• •Participating in another concurrent intervention study